Post-Operative Atrial Fibrillation Clinical Trial
Official title:
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A (AGN-151607) Injections Into the Epicardial Fat Pads to Prevent Post-Operative Atrial Fibrillation in Patients Undergoing Open-Chest Cardiac Surgery
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to evaluate the efficacy and safety of botulinum toxin type A (AGN-151607) injections into the epicardial fat pads, foci of ganglionic plexi, to prevent Post-Operative Atrial Fibrillation (POAF) in patients undergoing open-chest cardiac surgery.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05223725 -
Gene Therapy for Post-Operative Atrial Fibrillation
|
Phase 1 | |
| Recruiting |
NCT06124937 -
Empagliflozin to Prevent Post-Operative Atrial Fibrillation
|
Phase 3 | |
| Completed |
NCT03943927 -
Preemptive Pharmacogenetic-guided Metoprolol Management for PostoperativeAtrial Fibrillation in Cardiac Surgery
|
N/A | |
| Recruiting |
NCT04993456 -
Calcitonin Level and New-onset of Post-Operative Atrial Fibrillation
|
||
| Completed |
NCT03525860 -
Acupuncture Treatment for Patients Who Develop Arrhythmias in the Post-Operative Cardio-Thoracic Setting
|
N/A | |
| Completed |
NCT02701062 -
AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)
|
Phase 4 | |
| Recruiting |
NCT02029534 -
Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)
|
Phase 4 |